Equine sarcoids in horses: causes, forms and what owners should know

This article was created with the help of AI.

What a sarcoid in horses is

Equine sarcoid is by far the most common skin tumour in horses. It is a locally aggressive and infiltratively growing, semi-malignant skin neoplasia that can penetrate deeper tissue but does not metastasise to internal organs. For horse owners, this means: the condition is locally serious, but it does not form secondary tumours in the body.

The most common skin tumour in horses

In the veterinary literature, equine sarcoid occupies a central position. Studies show that sarcoids account for about 20 % of all tumours in horses and around 36 % of all skin tumours. In an evaluation by the Clinic for Horses at the University of Veterinary Medicine Hannover, the cases presented were predominantly geldings aged three to eight years. That evaluation only captured horses that were already affected, so no conclusions can be drawn about the risk for individual groups. No association with particular breeds or coat colours could be demonstrated there: sarcoids are found in every horse breed and every coat colour. In principle, horses of all breeds, coat colours and age groups can be affected.

Locally invasive, but without metastasis

Biologically, the equine sarcoid is a skin tumour of mesenchymal origin with variable epidermal involvement. The fibroblast proliferation primarily affects the dermis, and in rare cases the subcutis may also be involved. Despite its locally aggressive and infiltrative growth, metastasis is not observed. The sarcoid is a tumour that occurs only in the skin. For the owner, this means the condition can impair the local function of areas of skin, but the tumour itself does not spread via the blood or lymphatic system to distant organs.

Why a sarcoid is never a wart

In practice, early sarcoids are often mistakenly dismissed as harmless or confused with ordinary warts. The dermatological literature is clear on this point: sarcoids present clinically and histopathologically as genuine skin neoplasms and must expressly not be defined as warts. While true viral papillomas (warts) in young horses usually resolve spontaneously and disappear on their own, the equine sarcoid lacks this tendency towards self-limitation. Only the verrucous form shows a scaly, wart-like surface. The underlying cell structure, however, consists of altered connective tissue that persists without professional intervention or can become more aggressive.

• Semimalignant character: locally aggressive and infiltrative growth in the dermis and, in rare cases, the subcutis, without spread to internal organs.
• A true neoplasm: not a harmless skin growth or an ordinary wart, but a genuine connective tissue tumour.
• The most common skin tumour: it accounts for around 36 percent of all diagnosed skin tumours in horses.

The trigger: bovine papillomavirus

The development of the equine sarcoid is closely linked to infection with bovine papillomavirus types 1 and 2. In veterinary medicine, this virus is regarded as the primary triggering agent. However, the mere presence of viral DNA does not necessarily lead to tumour development, as additional genetic factors and local skin irritation must coincide.

BPV-1 and BPV-2 as primary triggers

Bovine papillomavirus, especially types 1 and 2, is today considered the decisive triggering agent of the equine sarcoid. University information for horse owners likewise names BPV-1 and BPV-2 as the cause of this semimalignant skin tumour. The route of transmission has not been fully established. Since BPV-1 has been detected in common fly species such as the housefly and stable fly, and sarcoids tend to develop at wound sites, flies are discussed as mechanical vectors. Indirect transmission via shared grooming equipment and tack or contaminated pastures is also considered possible.

Genetic predisposition and latent presence

The detection of BPV DNA is necessary for the development of a sarcoid, but it is by no means the sole cause. Studies have shown that viral papillomavirus DNA can also be detected in unchanged, clinically healthy equine skin. Why one horse develops tumours while the horse in the neighbouring stable remains free of them despite identical management conditions comes down to individual susceptibility. The specialist literature describes a genetic predisposition linked to specific genes of the major histocompatibility complex (MHC-II alleles). Direct transmission from horse to horse in the sense of a classic infectious disease is therefore considered very unlikely.

Harmless in cattle, aggressive in horses

From a virological perspective, BPV presents a fascinating cross-species phenomenon. In its natural host, cattle, bovine papillomavirus usually causes benign, self-limiting skin warts that die off after a time. When the virus is transmitted to the aberrant host, the horse, the clinical picture changes fundamentally. The horse's own immune system is often unable to adequately neutralise the virus in the dermal fibroblasts. Instead of a harmless epidermal change, a chronic, locally invasive proliferation of connective tissue develops. In addition, mechanical microtrauma or previous skin injuries act as catalysts, making it easier for the viruses to migrate into deeper skin layers.

• Triggering virus: Bovine papillomavirus types 1 and 2 (BPV-1/-2) as the primary agent.
• Possible vectors: Transmission by flying insects (pasture flies and stable flies) as well as contaminated grooming equipment and tack.
• Genetic component: Inherited predisposition via MHC-II alleles determines individual susceptibility.

The forms and where they occur

Equine sarcoid shows an extraordinarily varied appearance, divided into six main clinical forms. Common predilection sites are sparsely haired, moist skin areas or those subjected to mechanical stress from equipment, as well as previous injuries. Because the forms can overlap visually, accurate classification always requires an expert veterinary assessment.

The six clinical forms

In veterinary medicine, equine sarcoid is classified by its appearance into six distinct forms. The occult form is often noticeable only through hairless, mildly scaly skin areas. The verrucous form resembles crusty, wart-like thickening. Nodular sarcoids form firm nodules beneath the skin, while fibroblastic sarcoids emerge as fleshy, easily bleeding growths. Mixed forms combine features of several types. The malevolent form is rare, but grows extremely aggressively along lymphatic vessels and tissue septa.

Sarcoid form	Clinical appearance	Typical body regions
Occult	Flat, hairless, grey skin areas with a rough, asbestos-like surface	Head, eye region, inner thighs
Verrucous	Dry, crusty, scurfy or wart-like elevations with hyperkeratosis	Face, ear, ventral abdomen
Nodular	Firm, well-defined nodules in the dermis or subcutis; intact or ulcerated	Groin region, inner thighs, armpits
Fibroblastic	Fleshy, cauliflower-like growths; moist, bleeds easily on contact	Girth area, legs, groin, scar tissue
Mixed	Combination of two or more forms at the same site	Common in chronic or traumatised tumours
Malevolent	Very rare, infiltrative form with nodular cords along tissue layers	Elbow area, jaw angle, legs

Predilection sites and tissue trauma

Sarcoids tend to occur in specific regions of the body. These include moist skin folds on the inner thighs and in the genital area, thinly haired zones around the eyes and ears, and mechanically stressed areas such as the girth region or the lip commissure. Healed injuries and scar tissue also play a significant role. At sites of previous skin damage, tumour cells settle particularly easily. In addition, improper handling or constant manipulation of a mild form (for example an occult sarcoid) can cause the tumour to rapidly convert into a more aggressive, fibroblastic form.

Why visual diagnosis is not enough

Although the appearance often guides experienced vets towards a suspected diagnosis, purely visual differentiation between sarcoids, squamous cell carcinomas, melanomas or excessive granulation tissue is often unreliable. Histological examination of a tissue sample provides the only reliable confirmation. However, because a biopsy can stimulate a sarcoid into accelerated growth, the sample is in practice only taken once a concrete treatment plan has been established.

Why sarcoids often return after removal

The tendency to recur is the central clinical challenge in managing sarcoids. After surgical excision alone, studies report recurrence rates between 15 and 82 percent. Once a recurrence has already appeared and is treated again, the risk of further tumour formation rises dramatically and changes the long-term prognosis.

Recurrence risk with surgery as the sole therapy

Surgical removal of a sarcoid as the sole measure carries considerable risks. The specialist literature notes that the recurrence rate after surgical excision alone lies between 15 % and 82 %. The reason lies in the tumour's micro-mechanics: the tissue grows microscopically far beyond the visible margin. If not enough healthy tissue margin is removed during excision, invisible tumour cells or latent viral DNA remain in the apparently healthy surroundings. The trauma caused by the scalpel can additionally stimulate remaining tumour cells, so that the tumour regrows even more aggressively after the procedure.

The cascade of subsequent recurrences

A clinical study by Brandt et al. at the University of Veterinary Medicine Hannover, covering 58 patients with a total of 126 sarcoids, offers revealing insights into treatment resistance. Therapy there was associated with high recurrence rates, which depended on the number and location of the sarcoids as well as on the method chosen. Recurrences that had already occurred proved almost treatment-resistant when treated again. Monotherapy therefore rarely leads to success, while combination approaches can reduce the recurrence rate considerably.

The timeline of regrowth

The timing of recurrences shows that the decisive phase lies directly after the intervention. In the Hanover study, recurrences were observed overwhelmingly in the first months after treatment. Removed sarcoids frequently regrow within six months, and then more aggressively, which is attributed to the activation of latent viral DNA in the surrounding, apparently unchanged tissue. If a treated area remains unremarkable for longer, the likelihood of a late reappearance at the same site decreases.

• Recurrence rate after first surgery: 15 % to 82 % with surgical excision alone.
• High treatment resistance: recurrences are considered almost treatment-resistant after repeat treatment (58 patients, 126 sarcoids).
• Critical time window: regrowth frequently occurs within six months of the procedure.

What veterinary medicine offers

The veterinary management of sarcoids requires a tailored approach that takes into account the tumour's form, size, number and location. The therapeutic spectrum ranges from surgical and laser-assisted procedures to cryotherapy and immunotherapy, through to cytostatic topical preparations and radiation therapy. Because of the high biological variability, no universal solution exists.

Surgical and laser-assisted procedures

Surgical removal of well-demarcated sarcoids requires a safety margin of at least one to two centimetres into healthy tissue to capture nests that promote recurrence. The CO2 laser is increasingly used. During the incision, the laser seals blood and lymph vessels, reduces the risk of spreading tumour cells and sterilises the wound edges through heat, which can lower the recurrence rate. In specific cases, pedunculated, closely demarcated nodules can also be ligated.

Cryotherapy and immunotherapy

In cryosurgery, the tumour tissue is rapidly cooled to below minus 20 °C and then thawed slowly. Ice crystal formation destroys tumour cells in a targeted way, because neoplasias respond more sensitively to temperature fluctuations than healthy structures. Immunotherapy is considered an effective complement, for example with BCG vaccines (Bacillus Calmette-Guérin), which are injected locally and stimulate the horse's own immune system to mount a defence. Studies show that the combination of surgical excision and immunotherapy achieves markedly reduced recurrence rates compared with monotherapies.

Topical therapeutics, chemotherapy and radiation therapy

For smaller or difficult-to-operate sarcoids, local chemo- and immunotherapeutics are available. Depending on the findings, cisplatin injections or the topical application of preparations such as fluorouracil, imiquimod, acyclovir creams or cytostatic ointments (such as Liverpool ointment) are used. For sarcoids in critical locations such as the eyelid region or the limbs, brachytherapy (interstitial radiation therapy with radioisotopes such as iridium-192) offers very high success rates, but requires specialised centres. All of these measures are strictly veterinary treatments and may only be applied after an individual diagnosis by a vet.

• Laser and cryosurgery: thermal tissue destruction and edge sterilisation to minimise remaining tumour cells.
• Combination therapies: combining immunotherapy (e.g. BCG) with surgical procedures lowers the risk of recurrence.
• Prescription-only topical preparations: applied strictly under veterinary guidance and according to a tailored protocol.

What owners can do themselves, and what they cannot

The owner's role lies in attentive documentation, avoiding mechanical irritation and consistent fly protection in everyday stable life. Over-the-counter care products, feed supplements or home remedies can neither remove a sarcoid, shrink it, nor stop its growth. Applying substances to undiagnosed skin changes without thinking it through can trigger clinical reactions and make the diagnosis more difficult.

Useful measures in daily management

Horse owners can support veterinary care through considerate handling in the stable. Observe suspicious skin areas attentively. Photograph any change at regular intervals with a scale placed alongside, so you can document increases in size objectively. Adjust your equipment so that the headcollar, bridle, tack or girth does not rub on the affected zones. Consistent fly management with fly rugs and insect protection reduces the risk of vectors transferring the papillomavirus to other skin areas.

Clear limits: no effect from care products or home remedies

It must be stated unambiguously: no over-the-counter care product, no ointment, no supplement and no home remedy can dissolve, shrink or heal an equine sarcoid. Products for cosmetic cleansing and hygiene do support the general condition of healthy skin areas, but they have no influence whatsoever on the biological activity of connective tissue tumours. Attempts to deal with sarcoids on your own using caustic home remedies, harsh pastes or ligature threads frequently lead to massive tissue irritation. Such manipulation can activate a dormant occult sarcoid and trigger the rapid growth of aggressive fibroblastic tumours.

• Document: photograph regularly and compare measurements.
• Avoid irritation: consistently prevent pressure and friction from tack and equipment.
• Insect protection: curb transmission by fly vectors through stable and pasture management.
• No self-treatment: no experiments with home remedies, caustic ointments or improper ligation.

When to Call the Vet

Early veterinary examination is the single most important factor for a successful outcome with equine sarcoids. Every newly discovered skin growth, sudden change in size, surface change or bleeding requires immediate professional assessment. The smaller and less disturbed a sarcoid is at first presentation, the more manageable the options that remain.

Reasons for an Immediate Consultation

Do not wait until a skin change has reached a considerable size. Every academic equine clinic emphasises the same point: the smaller a sarcoid is at first diagnosis, the more straightforward it is to manage and the better the initial outlook. An immediate veterinary appointment is essential if you notice a new growth, if existing lumps grow rapidly, become moist or start to bleed, or if changes appear at mechanically sensitive sites such as the girth area, the head or the genitals.

Diagnose First, Then Act

Never apply ointments, oils or creams to an unclear skin change on your own initiative before the vet has examined the area. Even mild products can soften or alter the skin surface, which makes later tissue assessment and sampling more difficult. After the clinical examination, the vet will decide whether the change should be left alone and monitored or whether a targeted plan of care should be initiated. The earlier the change is professionally assessed, the more options remain open.

• New skin change: have any unclear thickening or hairless patch examined early.
• Warning signs: rapid growth, ulceration, bleeding or moisture require prompt assessment.
• No pre-treatment: keep the skin area completely untouched and clean until it has been assessed.